Lisa Meng

发表

Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM.

I. Olivotto, J. Januzzi, Amy Wohltman, 2024, Journal of the American College of Cardiology.

Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.

I. Olivotto, R. Barriales-Villa, M. Fifer, 2024, Journal of cardiac failure.

Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy.

I. Olivotto, Amy Wohltman, S. Kupfer, 2024, Journal of the American College of Cardiology.

Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy.

I. Olivotto, F. Roshanali, K. Jering, 2024, Journal of the American College of Cardiology.

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

J. Spertus, I. Olivotto, B. Claggett, 2024, The New England journal of medicine.